Discover how a new eye drop treatment may prevent the loss of vision associated with dry age-related macular degeneration, ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

Regeneron has bought Oxular, a UK-based specialist in retinal diseases, in a move that bolsters its already strong position ...

Macular degeneration is a leading cause of vision loss in people over 50. It affects the macula, the central part of the retina responsible for sharp, detailed vision. There are two types: dry macular ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of ...

Investigators conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of brolucizumab ...

Macular degeneration is a devastating eye condition that affects around 200 million people worldwide, primarily those over ...

In summary, CRISPR offers hope in the fight against aging-related diseases by targeting the underlying genetic causes. It has already shown promise in conditions like Alzheimer’s, heart disease, and ...